Characteristics of Patients with Severe Uncontrolled Asthma in Saudi Arabia: A Cross-Sectional Study. [PDF]
Al-Lehebi RO +10 more
europepmc +1 more source
Effectiveness of Benralizumab in Reducing Asthma and COPD Exacerbations in Patients with Severe Asthma and Concomitant COPD: Real-World Evidence from the ZEPHYR-5 Study. [PDF]
Adrish M +6 more
europepmc +1 more source
Clinical remission in patients with severe eosinophilic asthma treated with benralizumab over 24 months: Post hoc analysis of the ANANKE study. [PDF]
Canonica GW +22 more
europepmc +1 more source
Real-World Effectiveness of Biologic Therapies for Severe Asthma in a Diverse Middle Eastern Cohort: Evaluation of Longitudinal Symptom Improvement. [PDF]
Kareem MA +4 more
europepmc +1 more source
Real-World Effectiveness Following Benralizumab Use in Patients with Severe Eosinophilic Asthma in Romania: A Retrospective Cohort Study (BREEZE). [PDF]
Toma CL +6 more
europepmc +1 more source
Clinical Remission in Severe T2-High Asthma in Real Life After Anti-IgE, Anti-IL-5 and Anti-IL5R: A Potential Role for CRP as a Biomarker. [PDF]
Vervier J +12 more
europepmc +1 more source
From Anti-Neutrophil Cytoplasmic Antibody-Negative to Positive: Eosinophilic Granulomatosis with Polyangiitis Under Benralizumab After Steroid Cessation. [PDF]
Işık Ş +4 more
europepmc +1 more source
Functional respiratory imaging reveals early structural and functional airway responses to benralizumab in severe eosinophilic asthma. [PDF]
Conemans L +5 more
europepmc +1 more source
Comparative effectiveness of biologics in lung function improvement among patients with severe asthma: a real-world study. [PDF]
Bourdin A +12 more
europepmc +1 more source
Expert review and recommendations on the diagnosis and therapeutic management of eosinophilic granulomatosis with polyangiitis. [PDF]
Blanco R +7 more
europepmc +1 more source

